Edition TimeGlobal Study Synthetic Biology Market Chain, Dynamics and Key Players 2016 – 2026Digital JournalValley Cottage, NY — (SBWIRE) — 02/08/2018 — Synthetic Biology is one of the breakthrough technologies developed by mankind from chemistry, b… Continue reading
Head to Head Comparison: Editas Medicine (EDIT) versus …StockNewsTimesEditas Medicine (NASDAQ: EDIT) and PAREXEL International (NASDAQ:PRXL) are both healthcare companies, but which is the superior business? We will contrast the two companies based o… Continue reading
Innovative Sensor Fights Cancer Stem CellsControlled Environments MagazineMost cancer deaths are caused by recurrent or metastatic tumors. Conventional therapies target rapidly dividing tumor cells, but are unable to eradicate the highly chemoresistant… Continue reading
UtahHerald.com |
Abeona’s Sanfilippo Gene Therapy Data Produces Encouraging Results
Pharmaceutical Processing Abeona Therapeutics announces new phase 1/2 safety and biopotency data of investigational gene therapy for Sanfilippo syndrome at WORLDSymposium. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing novel cell and … Abeona’s gene therapy candidate for Sanfilippo B shows encouraging effect in first patient; shares up 12%Seeking Alpha Why Abeona Therapeutics Jumped 14% on WednesdayMadison.com Abeona Therapeutics (ABEO) Given Buy Rating at Maxim GroupThe Ledger Gazette Wolcott Daily –StockNewsTimes –Zacks –Zacks all 46 news articles » |
Drug Target Review |
CRISPR method efficiently corrects DMD defect in heart tissue
Drug Target Review Scientists have developed a CRISPR gene-editing technique that can potentially correct a majority of the 3,000 mutations that cause Duchenne muscular dystrophy (DMD) by making a single cut at strategic points along the patient’s DNA, according to a … |
The Stanford Daily |
Researchers combat cancer, Parkinson’s with CRISPR
The Stanford Daily Research from Stanford’s Qi Lab and published in Nature Communications is honing in on a method of using gene-editing to further the fight against leukemia and potentially other cancers. Bioengineering and chemical systems biology professor Stanley Qi … |